ES
MARKETS / NYSE / CVS
NYSE · RETAIL-DRUG STORES AND PROPRIETARY STORES · LARGE CAP

CVS Health Corp. CVS

19 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$402.1B
▲ 7.8% vs FY2024
EPS · FY25
$1.39
Dividend / sh · FY25
$2.66
Payout · FY25
192%
ROE · FY25
2.3%
Net margin · FY25
0.4%
Dividend coverage
0.5×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 402.1B
Revenue, FY2025 · full 19-year series below
Revenue Net income
200400600402.11.82007201020132016201920222025
200400600402.11.82016201920222025

0 cents of every revenue dollar became profit this year.

Per share
USD 1.39
Diluted EPS, FY2025
EPS Dividend
2.557.52.661.392007201020132016201920222025
2.557.52.661.392016201920222025

Earnings covered only a fraction of the dividend — the rest came from cash or borrowing.

Profitability
2.3%
Return on equity, FY2025
ROE
51015202.3%2007201020132016201920222025
51015202.3%2016201920222025
Operating margin1.2%
Net margin0.4%
Return on assets0.7%

Each USD of equity produced 2 cents of profit this year.

Returned to shareholders
USD 3.4B
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 3.4B
Net buybacksUSD -394.0M
Share of profit192.1%
Consecutive raises—

USD 3.4B in dividends — 192% of the year's profit, so the payout drew on cash built up earlier.

Growth
+8.4% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+7.6%
+8.4%
+10.1%
+10.0%
Net income
−25.7%
−24.4%
−10.3%
−4.3%
EPS, diluted
−24.7%
−23.9%
−11.3%
−3.8%
Dividend / share
+6.5%
+5.9%
+6.6%
+14.5%
Returned to shareholders
−16.6%
+5.3%
−5.9%
+4.7%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
1.27B
Shares outstanding, FY2025
1.441.272007201020132016201920222025
1.061.272016201920222025
Change, 5 years−3.0%
Change, 10 years+15.4%

The share count shrank 3% in five years — the same company, cut into fewer, larger slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 253.5B
total assets, end of FY2025
Total assetsUSD 253.5B
EquityUSD 75.2B
CashUSD 8.5B
Gross debtUSD 60.5B
Net debtUSD 52.0B
Current ratio0.84×

Net debt stands at 69% of equity.

History
19 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Revenue $B
402.1
372.8
357.8
322.5
292.1
268.7
256.8
194.6
184.8
177.5
153.3
139.4
126.8
123.1
107.1
95.8
98.2
87.5
76.3
Operating income $B
4.7
8.5
13.7
8.0
13.3
13.9
12.0
4.0
9.5
10.4
9.5
8.8
8.0
7.2
6.3
6.1
6.4
6.0
4.8
EBITDA $B
9.3
13.1
18.1
12.2
17.8
18.4
16.4
6.7
12.0
12.9
11.6
10.2
9.4
8.5
7.4
7.1
·
·
·
Income tax $B
0.4
1.6
2.8
1.5
2.5
2.6
2.4
2.0
1.6
3.3
3.4
3.0
2.9
2.4
2.3
2.2
2.2
2.2
1.7
Net income $B
1.8
4.6
8.3
4.3
8.0
7.2
6.6
−0.6
6.6
5.3
5.2
4.6
4.6
3.9
3.5
3.4
3.7
3.2
2.6
EPS, diluted $
1.39
3.66
6.47
3.26
6.02
5.46
5.08
−0.57
6.44
4.90
4.63
3.96
3.74
3.02
2.57
2.49
2.55
2.18
1.92
Dividend / sh $
2.66
2.66
2.42
2.20
2.00
2.00
2.00
2.00
2.00
1.70
1.40
1.10
0.90
0.65
0.50
0.35
0.30
0.26
0.23
Payout %
192
73
38
67
33
37
39
−343
31
35
30
28
24
21
19
14
12
12
12
ROE %
2.3
6.1
11.3
5.9
11.1
10.8
10.9
−1.2
17.8
14.4
13.9
12.2
12.1
10.3
9.2
9.3
10.5
9.7
8.4
Shares out B
1.27
1.26
1.29
1.30
1.32
1.31
1.30
1.29
1.01
1.06
1.10
1.14
1.18
1.23
1.30
1.36
1.39
1.44
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
66 of 66
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed